Certified by Founder Lodge
Matchpoint Therapeutics

START UP
1 Disclosed Funding Rounds $100,000,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Matchpoint is a biotechnology company harnessing the power of covalency to discover precision covalent medicines to transform the treatment of immune diseases and other serious illnesses. The
Date | Round | Raised | Participating Investors |
---|---|---|---|
October, 17 ,2022 | Series A | $100,000,000 |